AEZS Aeterna Zentaris Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

AEZS [NASD]

Aeterna Zentaris Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.02	Insider Own	0.60%	Shs Outstand	21.52M	Perf Week	0.87%
Market Cap	27.00M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	23.28M	Perf Month	58.90%
Income	-0.40M	PEG	-	EPS next Q	-	Inst Own	21.40%	Short Float	0.32%	Perf Quarter	48.66%
Sales	1.60M	P/S	16.88	EPS this Y	-240.50%	Inst Trans	4.62%	Short Ratio	0.19	Perf Half Y	29.61%
Book/sh	0.08	P/B	14.50	EPS next Y	-	ROA	-1.70%	Target Price	-	Perf Year	-58.72%
Cash/sh	0.40	P/C	2.94	EPS next 5Y	-	ROE	23.50%	52W Range	0.40 - 3.11	Perf YTD	27.47%
Dividend	-	P/FCF	-	EPS past 5Y	58.80%	ROI	628.40%	52W High	-62.70%	Beta	1.98
Dividend %	-	Quick Ratio	3.30	Sales past 5Y	117.20%	Gross Margin	19.70%	52W Low	192.75%	ATR	0.10
Employees	11	Current Ratio	3.50	Sales Q/Q	2845.90%	Oper. Margin	-	RSI (14)	68.92	Volatility	7.51% 11.71%
Optionable	Yes	Debt/Eq	0.18	EPS Q/Q	111.90%	Profit Margin	-22.20%	Rel Volume	0.36	Prev Close	1.14
Shortable	Yes	LT Debt/Eq	0.06	Earnings	-	Payout	-	Avg Volume	399.87K	Price	1.16
Recom	-	SMA20	11.62%	SMA50	39.92%	SMA200	10.93%	Volume	142,240	Change	1.31%

Jul-19-17

Reiterated

Maxim Group

Buy

$2 → $4

May-10-17

Reiterated

H.C. Wainwright

Buy

$7.50 → $3

May-01-17

Reiterated

Maxim Group

Buy

$11 → $2

Jan-17-17

Reiterated

Maxim Group

Buy

$7 → $10

Dec-02-15

Reiterated

H.C. Wainwright

Buy

$11 → $12

Nov-24-15

Reiterated

H.C. Wainwright

Buy

$0.11 → $11

Nov-23-15

Reiterated

Maxim Group

Buy

$200 → $11

Apr-14-15

Upgrade

H.C. Wainwright

Neutral → Buy

$1.25

Nov-06-14

Downgrade

H.C. Wainwright

Buy → Neutral

Jul-17-14

Initiated

H.C. Wainwright

Buy

Jan-03-13

Upgrade

MLV & Co

Hold → Buy

$5.50

Oct-09-12

Initiated

Maxim Group

Buy

Apr-02-12

Downgrade

MLV & Co

Buy → Hold

Jun-07-11

Initiated

Oppenheimer

Outperform

$5.50

Apr-27-11

Reiterated

Canaccord Genuity

Speculative Buy

$2.75 → $4

Nov-29-10

Initiated

MLV Capital

Buy

$5.50

Feb-05-09

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

Jun-03-08

Reiterated

Canaccord Adams

Buy

$3.20 → $2.65

Apr-14-08

Reiterated

Canaccord Adams

Buy

$4.50 → $3.20

Oct-03-07

Reiterated

Rodman & Renshaw

Mkt Outperform

$8 → $6

May-15-20 04:45PM	Aeterna Zentaris Announces Results of 2020 Annual Meeting of Shareholders GlobeNewswire
May-08-20 09:00AM	Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders GlobeNewswire
May-06-20 08:05AM	Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results GlobeNewswire +31.54%
May-03-20 07:30PM	One Biotech Stock For 2020 Oilprice.com
Apr-30-20 03:08PM	Gilead's remdesivir will set new standard of care for coronavirus treatment: Fauci Yahoo Finance Video
Apr-15-20 04:06PM	Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing GlobeNewswire
09:15AM	Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit GlobeNewswire
Apr-07-20 01:00PM	AETERNA ZENTARIS ANNOUNCES EMA DECISION TO ACCEPT A MODIFICATION TO AN AGREED PEDIATRIC INVESTIGATION PLAN FOR MACIMORELIN GlobeNewswire
Apr-06-20 09:00AM	AETERNA ZENTARIS ANNOUNCES POSITIVE RESULTS IN DOSE-FINDING PEDIATRIC STUDY OF MACIMORELIN GlobeNewswire +55.72%
Apr-03-20 10:36AM	We'll weather the coronavirus storm well and come out very strong: Cigna Services President Yahoo Finance Video
Mar-30-20 05:00PM	AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE GlobeNewswire -8.51%
Mar-12-20 08:00AM	AETERNA ZENTARIS ANNOUNCES SETTLEMENT OF PREVIOUSLY DISCLOSED CLASS-ACTION LAWSUIT GlobeNewswire -17.74%
Feb-21-20 02:00PM	Aeterna Zentaris Announces Closing of $4.5 Million Registered Direct Offering Priced At-The-Market GlobeNewswire
Feb-20-20 07:06AM	The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study Benzinga -25.00%
Feb-19-20 07:00PM	Aeterna Zentaris Announces $4.5 Million Registered Direct Offering Priced At-The-Market GlobeNewswire
Feb-12-20 08:05AM	Aeterna Zentaris to Present at Noble Capital Markets' 16th Annual Investor Conference GlobeNewswire
Jan-28-20 08:00AM	Aeterna Zentaris Announces Completion of Patient Recruitment in Dose-Finding Pediatric Study of Macimorelin GlobeNewswire
Jan-27-20 08:35AM	Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement for Continued Listing GlobeNewswire
Jan-09-20 08:39AM	The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results Benzinga -9.02%
Jan-08-20 04:01PM	Aeterna Zentaris Receives NASDAQ Notification Regarding Minimum Bid Price Requirement GlobeNewswire +14.42%
Dec-30-19 06:38AM	Companies Like Aeterna Zentaris (TSE:AEZS) Can Be Considered Quite Risky Simply Wall St. +15.20%
Dec-20-19 05:45PM	Hedge Funds Have Never Been This Bullish On AEterna Zentaris Inc. (AEZS) Insider Monkey
Dec-18-19 09:00AM	Aeterna Zentaris Announces Publication of GHD Management Guidelines GlobeNewswire
Dec-16-19 09:00AM	Aeterna Zentaris Announces 2020 Director Changes GlobeNewswire
Nov-07-19 06:28PM	Aeterna Zentaris Reports Third Quarter 2019 Financial and Operating Results GlobeNewswire
Nov-05-19 07:56AM	Top Ranked Value Stocks to Buy for November 5th Zacks +7.46%
Oct-29-19 10:33AM	Analysts Estimate Aeterna Zentaris (AEZS) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-08-19 09:00AM	What Makes Aeterna Zentaris (AEZS) a New Buy Stock Zacks
Oct-04-19 04:59PM	Aeterna Zentaris Announces Appointment of New President and Chief Executive Officer GlobeNewswire
Sep-26-19 06:34AM	Can We See Significant Institutional Ownership On The Aeterna Zentaris Inc. (TSE:AEZS) Share Register? Simply Wall St. -5.13%
Sep-24-19 04:01PM	Aeterna Zentaris Announces Closing of Approximately $5.0 Million Registered Direct Offering GlobeNewswire
Sep-20-19 11:00AM	Aeterna Zentaris Announces Pricing of Approximately $5.0 Million Registered Direct Offering GlobeNewswire -22.42%
Aug-20-19 11:16PM	Aeterna Zentaris Announces Director Change GlobeNewswire
Aug-13-19 05:45PM	Aeterna Zentaris (AEZS) Beats Q2 Earnings Estimates Zacks +11.16%
04:15PM	Aeterna Zentaris Reports Second Quarter 2019 Financial and Operating Results GlobeNewswire
Aug-01-19 10:33AM	Will Aeterna Zentaris (AEZS) Report Negative Q2 Earnings? What You Should Know Zacks -5.20%
Jul-01-19 10:30AM	Options Traders Expect Huge Moves in Aeterna Zentaris (AEZS) Stock Zacks
Jun-06-19 02:06PM	Aeterna Zentaris Provides Corporate Update GlobeNewswire -13.38%
May-08-19 06:04PM	Aeterna Zentaris Announces Results of Annual and Special Shareholders Meeting GlobeNewswire -11.32%
May-07-19 07:25PM	Aeterna Zentaris (AEZS) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:22PM	Aeterna Zentaris: 1Q Earnings Snapshot Associated Press
05:12PM	Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results GlobeNewswire
May-02-19 10:02AM	What's in the Cards for AEterna (AEZS) This Earnings Season? Zacks
Apr-29-19 10:31AM	Analysts Estimate Aeterna Zentaris (AEZS) to Report a Decline in Earnings: What to Look Out for Zacks
Mar-26-19 07:50PM	Aeterna Zentaris: 4Q Earnings Snapshot Associated Press
05:22PM	Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results GlobeNewswire
Mar-19-19 08:00AM	Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019 GlobeNewswire +5.50%
Mar-18-19 11:18AM	Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade Zacks
Mar-13-19 07:27AM	The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie Benzinga +8.40%
Mar-12-19 04:32PM	Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor GlobeNewswire
Mar-04-19 08:58AM	What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks -5.50%
Feb-27-19 09:57AM	The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris Zacks
Feb-26-19 08:55AM	4 Drug Stocks to Buy Despite Price Hearing Woes Zacks
Feb-14-19 10:45AM	The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna Zacks
Feb-13-19 08:36AM	5 Tiny Biotech Stocks With Superb Growth Potential Zacks
Jan-29-19 09:30AM	Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year? Zacks
08:48AM	Implied Volatility Surging for Aeterna Zentaris (AEZS) Stock Options Zacks
Jan-16-19 09:03AM	Aeterna Zentaris Receives European Marketing Clearance for Macimorelin GlobeNewswire -10.00%
Jan-09-19 09:50AM	Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan Zacks
Jan-07-19 09:30AM	Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year? Zacks
Dec-24-18 05:50PM	Aeterna Zentaris (AEZS) Stock Moves -1.16%: What You Should Know Zacks
Dec-21-18 05:04PM	Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore GlobeNewswire -5.82%
Dec-20-18 09:30AM	Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-17-18 05:50PM	Aeterna Zentaris (AEZS) Gains As Market Dips: What You Should Know Zacks
Dec-07-18 05:45PM	Aeterna Zentaris (AEZS) Stock Moves -0.54%: What You Should Know Zacks
Dec-04-18 12:51PM	Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year? Zacks -5.43%
Nov-30-18 05:41AM	Can The Uptrend Continue for Aeterna Zentaris (AEZS)? Zacks +7.64%
Nov-19-18 09:00AM	4 Healthcare Stocks Taking a New Approach to Growth Trends ACCESSWIRE
08:00AM	Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency GlobeNewswire
Nov-16-18 10:50AM	4 Healthcare Stocks Turning Toward Tech For New Growth ACCESSWIRE +14.17%
07:40AM	Consolidated Research: 2018 Summary Expectations for Western Gas Partners, LP, HCA Healthcare, DHI Group, AEterna Zentaris, Tsakos Energy Navigation, and Acme United Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-06-18 07:54PM	Aeterna Zentaris: 3Q Earnings Snapshot Associated Press
06:14PM	Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results GlobeNewswire
08:00AM	Aeterna Zentaris Settles Dispute with Cogas Consulting, LLC GlobeNewswire
Nov-01-18 08:20AM	Aeterna Zentaris Soars on Macrilen(TM) Out Licensing Deal, Analysts Review and Target ACCESSWIRE
08:00AM	Aeterna Zentaris Announces Novo Nordisk to acquire rights to Macrilen in United States and Canada GlobeNewswire
07:50AM	Todays Research Reports on Stocks to Watch: Aeterna Zentaris and AbbVie ACCESSWIRE
Oct-31-18 04:05PM	Aeterna Zentaris to Announce Third Quarter 2018 Financial and Operating Results on November 6, 2018 GlobeNewswire +67.69%
12:00PM	3 Healthcare Stocks Leading New Industry Trends ACCESSWIRE
Sep-25-18 08:00AM	Aeterna Zentaris Appoints Leslie Auld as Chief Financial Officer GlobeNewswire
Aug-10-18 07:27AM	What is Behind Aeterna Zentaris Incs (TSE:AEZS) Superior ROE? Simply Wall St.
06:30AM	Aeterna Zentaris Inc. to Host Earnings Call ACCESSWIRE
Aug-09-18 06:57PM	Aeterna Zentaris: 2Q Earnings Snapshot Associated Press
04:19PM	Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results GlobeNewswire
Aug-02-18 04:05PM	Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018 GlobeNewswire
May-31-18 04:15PM	Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH GlobeNewswire -9.54%
May-29-18 08:44AM	Mirati Therapeutics (MRTX) Soars: Stock Adds 13.6% in Session Zacks +12.96%
May-25-18 08:44AM	VIVUS (VVUS) in Focus: Stock Moves 5.6% Higher Zacks +6.41%
May-24-18 08:46AM	MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session Zacks
May-16-18 08:45AM	Inovio Pharmaceuticals (INO) in Focus: Stock Moves 5.7% Higher Zacks
May-14-18 02:10PM	5 Top Profitable Stocks With Terrific Growth InvestorPlace
09:47AM	Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors Zacks
May-11-18 09:24AM	5 Top Profitable Stocks With Terrific Growth in the Offing Zacks +6.87%
May-08-18 04:15PM	Aeterna Zentaris Announces Results of Annual and Special Shareholders Meeting GlobeNewswire -5.79%
07:55AM	Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure Benzinga
May-07-18 06:41PM	Aeterna Zentaris: 1Q Earnings Snapshot Associated Press
04:15PM	Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results GlobeNewswire
May-01-18 05:05PM	Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 2018 GlobeNewswire
Apr-19-18 07:20AM	Wired News Anavex Life Sciences To Commence Phase-2 Study of ANAVEX(R)2-73 in Parkinsons Disease Dementia ACCESSWIRE
Apr-09-18 08:00AM	Aeterna Zentaris Files Management Information Circular GlobeNewswire

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience